HAPASIL SUSPENSION ORAL 150 mg/ml
-
Netobimin
-
Surrendered
Authorised in these countries:
-
Spain
Product identification
Medicine name:
HAPASIL SUSPENSION ORAL 150 mg/ml
Active substance and strength:
-
Netobimin
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC06
Authorisation number:
- 242 ESP
Product identification number:
- 253800b0-fb5c-4445-8261-93436d7014cc
Permanent identification number:
- 600000058888
Product details
Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Meat and offal12day
-
Milk3day
-
Availability
Package description:
- Available only in Español
Manufacturing sites for batch release:
- Trirx Segre
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.
Authorisation details
Authorisation status:
-
Surrendered
Authorisation procedure type:
-
Marketing Authorisation
Procedure number:
- 242 ESP
Date of authorisation status change:
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Authorisation country:
-
Spain
Responsible authority:
- (AEMPS)
Marketing authorisation holder:
- Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.
Additional information
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
First published:
Last updated:
Labelling
(PDF)
First published:
Last updated:
Package Leaflet
(PDF)
First published:
Last updated:
How useful was this page?: